Envoy Medical, Inc. (COCH) Reports Q3 Loss, Misses Revenue Estimates
Envoy Medical, Inc. (COCH) delivered earnings and revenue surprises of -29.63% and -23.64%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?